Auxly Cannabis Group Inc. (TSE:XLY) shareholders have had their patience rewarded with a 44% share price jump in the last month. The annual gain comes to 283% following the latest surge, making investors sit up and take notice.
Following the firm bounce in price, given close to half the companies operating in Canada’s Pharmaceuticals industry have price-to-sales ratios (or “P/S”) below 0.6x, you may consider Auxly Cannabis Group as a stock to potentially avoid with its 1.2x P/S ratio. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s as high as it is.
View our latest analysis for Auxly Cannabis Group


